Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity)
AssigneePro Natura Gesellschaft FüR Gesunde ErnäHrung GmbH
InventorsDaniel Henry Wyrobnik, Isaac Harry Wyrobnik
Life of this patent
Estimating the term…
Abstract
There are disclosed compositions and methods for treating obesity using 5-D-fructose dehydrogenase. Other embodiments are also described.
Claims20
A mammalian ingestible composition which is adapted for oral administration selected from a pharmaceutical composition and a dietary supplement, said composition being in unit dosage form and is selected from the group consisting of a tablet, capsule, gel cap and dragée, said composition comprising 5-D-fructose dehydrogenase and a carrier or excipient that is acceptable for use in pharmaceutical compositions or foodstuffs, said composition further comprising a second enzyme selected from the group consisting of a glucose isomerase, lactase, alpha-amylase, beta-amylase, glucoamylase, pullulanase, isoamylase, amyloglucosidase, cyclomaltodextrine glucanotransferase, and mixtures thereof, wherein said 5-D-fructose dehydrogenase constitutes between 10 and 99.9% by weight of the composition.
Dependencies are inferred from the claim text.